Candriam Equities L Oncology Impact C/ LU1864481541 /
| NAV10/06/2024 | Chg.-0.1900 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 235.7400USD | -0.08% | paying dividend | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 11/06/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 03/06/2024 | Prospectus | 2024 | English | 3,663.84 KB |
| 03/06/2024 | Prospectus | 2024 | German | 5,520.88 KB |
| 01/03/2024 | PRIIP Key Information Document | 2024 | English | 261.97 KB |
| 01/03/2024 | PRIIP Key Information Document | 2024 | German | 269.13 KB |
| 31/12/2023 | Account statment | 2023 | English | 5,416.37 KB |
| 31/12/2023 | Account statment | 2023 | German | 4,732.66 KB |
| 30/06/2023 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 30/06/2023 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 02/07/2022 | Key Investor Information | 2022 | English | 296.11 KB |
| 02/07/2022 | Key Investor Information | 2022 | German | 363.61 KB |
